Literature DB >> 10455894

Gastrin-mediated effects of omeprazole on rat colon mucosa.

M E Klingensmith1, L J Neville, E Delpire, M M Wolfe, D I Soybel.   

Abstract

BACKGROUND: Omeprazole increases circulating gastrin levels, which in turn may affect the growth and differentiation of colon mucosa. Chloride transport mechanisms in normal colon were analyzed as markers for possible trophic actions of endogenous hypergastrinemia.
METHODS: Four groups of Fischer rats were studied for 10 days. Group 1 (baseline) received no treatment. Group 2 received omeprazole only. Group 3 received omeprazole plus vehicle. Group 4 received omeprazole plus CCK-B gastrin receptor antagonist (GRA) L740,093 in vehicle. On day 10 serum gastrin was assayed. Colon mucosa was analyzed for protein and DNA content. Semiquantitative Northern analysis measured levels of messenger RNA (mRNA) encoding for key Cl- transporters: Na-K-Cl cotransporter (Cl- secretion in crypts), Cl-/HCO3- exchanger (Cl- absorption in villi), and Na/K adenosine triphosphatase (not directly involved in Cl- transport).
RESULTS: Omeprazole increased gastrin levels, which were not altered by vehicle or GRA. Omeprazole increased protein, DNA, and Na/K adenosine triphosphatase mRNA levels, with no effect by GRA. In contrast, omeprazole decreased Na-K-Cl and Cl-/HCO3- mRNA levels, effects that were partly reversed by GRA.
CONCLUSIONS: Omeprazole augments growth index values of colon mucosa independent of serum gastrin. Against a background of omeprazole-induced achlorhydria hypergastrinemia appears to influence differentiation rather than growth of normal colon mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455894

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

2.  Factors Favouring the Development of Clostridium Difficile Infection in Critically Ill Patients.

Authors:  Bianca-Liana Grigorescu; Raluca Ştefania Fodor; Adrian Dan Cioc; Mihaly Veres; Monica Orlandea; Bogdan Lăzescu; Emoke Almasy
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

3.  COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.

Authors:  M Yao; D H Song; B Rana; M M Wolfe
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.